DMAC vs MRVI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

DMAC

49.9
AI Score
VS
MRVI Wins

MRVI

55.0
AI Score

Investment Advisor Scores

DMAC

50score
Recommendation
HOLD

MRVI

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DMAC MRVI Winner
Net Income -10.04M -130.80M DMAC
Operating Income -10.48M -215.27M DMAC
ROE -21.3% -61.6% DMAC
ROA -18.9% -17.0% MRVI
Total Assets 53.08M 770.58M MRVI
Cash 4.87M 216.89M MRVI
Current Ratio 9.11 6.60 DMAC
Free Cash Flow -9.09M -70.72M DMAC

Relative Price Performance (Last 90 Days)

DMAC 1M: -18.5% · 3M: +7.9% MRVI 1M: +8.4% · 3M: +68.7%

Current Technical Phase

DMAC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.3 · Price: $6.53

MRVI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.9 · Price: $6.40

Fundamentals Snapshot

Metric DMAC MRVI
Market Cap
Forward P/E -7.4 -70.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.4%
Gross Margin 0.3%
Operating Margin 0.0% 0.0%
EPS -0.71 -0.71
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MRVI is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.